Alzheimer’s Disease Prevention
Tech ID
P35-1350
Patent Status
Published in India
Design Status
--
Technical Description
The present invention relates to synthesis of novel sulfonamide derivatives of para-amino benzoic acid as selective butrylcholinesterase (BuChE) inhibitors for the treatment of Alzheimer’s disease.
Problems Addressed
- Neurodegeneration
- Acetylcholine Depletion
- Ineffective Existing Treatments
- Undesirable Side Effects
TARGET AUDIENCE
- Medical and Healthcare Sector
- Pharmaceutical Industry
- Biotechnology Firms
- Research & Development
TECH FEATURES
- Novel Compound
- Selective BuChE Inhibitor
- Low Ic50 Value
- Prevention and Delayed Alzheimer
- Targeted Treatment
- Minimal Side Effects
P35-1350
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com